IRCCS Humanitas Research Hospital
Verified site
Rozzano, Italy
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
Deep vein thrombosis is a condition where a blood clot forms in a deep vein, most often in the leg, and it can be more common during pregnancy. The study uses enoxaparin sodium, a medication that belongs to the class of low molecular weight heparin and is given as a small injection under the skin to prevent the clot from growing and to reduce the chance of new clots forming.
The purpose of the study is to find out whether a slightly lower dose of the medication works as well as the full dose in stopping another clot, including a clot that could travel to the lung called pulmonary embolism, after an initial six‑week period of full‑dose treatment. Participants will first receive the standard dose for six weeks, then they will be randomly assigned to continue either the standard dose or a reduced dose until after delivery, and they will be followed until about 12 weeks after the baby is born (postpartum) to see if any new clot occurs. The study also watches for serious side effects such as major bleeding, noticeable but less serious bleeding known as clinically relevant non-major bleeding, and heavy bleeding after birth referred to as postpartum haemorrhage. Simple explanations are provided during the study to help participants understand these terms.
The trial runs in 6 steps – from screening to follow-up. Each step says what happens and what the team monitors.
5 criteria
15 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.